Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Hampton SL"'
Autor:
Hampton, SL, Griffiths, CL
Publikováno v:
African Journal of Marine Science; Vol 29, No 1 (2007); 123-126
The European green crab Carcinus maenas has established considerable breeding populations in harbours and sheltered bays in the South-Western Cape, South Africa, but appears unable to flourish on the wave exposed coastline. This study compares the ab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::ba1f4f95222781f921a4ee8cd419e95e
https://www.ajol.info/index.php/ajms/article/view/33453
https://www.ajol.info/index.php/ajms/article/view/33453
Autor:
Allison M; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom., Davie RL; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Mogg AJ; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Hampton SL; KalVista Pharmaceuticals Limited, Salisbury, SP4 0BF, United Kingdom., Emsley J; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom., Stocks MJ; Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, United Kingdom.
Publikováno v:
ACS medicinal chemistry letters [ACS Med Chem Lett] 2024 Mar 28; Vol. 15 (4), pp. 501-509. Date of Electronic Publication: 2024 Mar 28 (Print Publication: 2024).
Autor:
Clermont AC; KalVista Pharmaceuticals, Cambridge, United Kingdom., Murugesan N; KalVista Pharmaceuticals, Cambridge, United Kingdom., Edwards HJ; KalVista Pharmaceuticals, Cambridge, United Kingdom., Lee DK; KalVista Pharmaceuticals, Cambridge, United Kingdom., Bayliss NP; KalVista Pharmaceuticals, Cambridge, United Kingdom., Duckworth EJ; KalVista Pharmaceuticals, Cambridge, United Kingdom., Pethen SJ; KalVista Pharmaceuticals, Cambridge, United Kingdom., Hampton SL; KalVista Pharmaceuticals, Cambridge, United Kingdom., Gailani D; Hematology/Oncology Division, Vanderbilt University, Nashville, TN, United States., Feener EP; KalVista Pharmaceuticals, Cambridge, United Kingdom.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2023 Dec 19; Vol. 14, pp. 1287487. Date of Electronic Publication: 2023 Dec 19 (Print Publication: 2023).
Autor:
Davie RL; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Edwards HJ; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Evans DM; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Hodgson ST; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Stocks MJ; School of Pharmacy, University of Nottingham, University Park Campus, Nottingham NG7 2RD, U.K., Smith AJ; Sygnature Discovery, Biocity, Pennyfoot Street, Nottingham, NG1 1GR, U.K., Rushbrooke LJ; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Pethen SJ; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Roe MB; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K., Clark DE; Charles River Early Discovery, 6-9 Spire Green Centre, Harlow, Essex CM19 5TR, U.K., McEwan PA; Evotec, 114 Innovation Drive Milton Science Park, Abingdon, OX14 4RZ, U.K., Hampton SL; KalVista Pharmaceuticals Limited, Porton Science Park, Salisbury, SP4 0BF, U.K.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2022 Oct 27; Vol. 65 (20), pp. 13629-13644. Date of Electronic Publication: 2022 Oct 17.
Autor:
Duckworth EJ; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Murugesan N; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Li L; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Rushbrooke LJ; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Lee DK; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., De Donatis GM; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Maetzel A; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA.; Institute for Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada., Yea CM; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Hampton SL; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA., Feener EP; KalVista Pharmaceuticals, Cambridge, Massachusetts, USA.
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology [Clin Exp Allergy] 2022 Sep; Vol. 52 (9), pp. 1059-1070. Date of Electronic Publication: 2022 Mar 20.
Autor:
Maetzel A; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass; Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada., Smith MD; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Duckworth EJ; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Hampton SL; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., De Donatis GM; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Murugesan N; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Rushbrooke LJ; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Li L; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass., Francombe D; Simbec-Orion Ltd, Merthyr Tydfil, United Kingdom., Feener EP; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass. Electronic address: epf@kalvista.com., Yea CM; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
Publikováno v:
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2022 Jun; Vol. 149 (6), pp. 2034-2042. Date of Electronic Publication: 2022 Jan 24.
Autor:
Hampton SL; Department of Rheumatology, Aberdeen Royal Infirmary, Aberdeen, UK., Youssef H
Publikováno v:
BMJ case reports [BMJ Case Rep] 2013 Jan 25; Vol. 2013. Date of Electronic Publication: 2013 Jan 25.
Autor:
Hampton SL; Vantia Ltd., Southampton, UK. Sally.Hampton@Vantia.com, Kinnaird AI
Publikováno v:
Cell biology and toxicology [Cell Biol Toxicol] 2010 Feb; Vol. 26 (1), pp. 43-55. Date of Electronic Publication: 2009 Nov 11.
Autor:
Yea CM; Vantia Ltd, Southampton Science Park, Southampton SO16 7NP, United Kingdom. chris.yea@vantiatherapeutics.com, Allan CE, Ashworth DM, Barnett J, Baxter AJ, Broadbridge JD, Franklin RJ, Hampton SL, Hudson P, Horton JA, Jenkins PD, Penson AM, Pitt GR, Rivière P, Robson PA, Rooker DP, Semple G, Sheppard A, Haigh RM, Roe MB
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2008 Dec 25; Vol. 51 (24), pp. 8124-34.
Autor:
Frei CR; College of Pharmacy, The University of Texas, Austin, Texas, USA., Hampton SL, Burgess DS
Publikováno v:
Clinical therapeutics [Clin Ther] 2006 Jul; Vol. 28 (7), pp. 1035-40.